Inhibition of Cellular Proliferation through I{kappa}B Kinase-Independent and Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Repression of Cyclin D1

doi:10.1128/MCB.21.9.3057-3070.2001

This Article

	Full Text
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Reprints and Permissions
	Copyright Information
	Books from ASM Press
	MicrobeWorld

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Wang, C.
	Articles by Pestell, R. G.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Wang, C.
	Articles by Pestell, R. G.

Previous Article | Next Article

Molecular and Cellular Biology, May 2001, p. 3057-3070, Vol. 21, No. 9
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.3057-3070.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Inhibition of Cellular Proliferation through I $kappa$ B Kinase-Independent and Peroxisome Proliferator-Activated Receptor $gamma$ -Dependent Repression of Cyclin D1

Chenguang Wang,¹ Maofu Fu,¹ Mark D'Amico,¹ Chris Albanese,¹ Jian-Nian Zhou,¹ Michael Brownlee,¹ Michael P. Lisanti,² V. Krishna K. Chatterjee,³ Mitchell A. Lazar,⁴ and Richard G. Pestell¹^,^*

Departments of Developmental and Molecular Biology and Medicine, The Albert Einstein Cancer Center,¹ and Department of Pharmacology, Albert Einstein College of Medicine,² Bronx, New York 10461; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, United Kingdom³; and Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104⁴

Received 6 September 2000/Returned for modification 9 October 2000/Accepted 13 February 2001

The nuclear receptor peroxisome proliferator-activated receptor $gamma$ (PPAR $gamma$ ) is a ligand-regulated nuclear receptor superfamilymember. Liganded PPAR $gamma$ exerts diverse biological effects, promotingadipocyte differentiation, inhibiting tumor cellular proliferation,and regulating monocyte/macrophage and anti-inflammatory activitiesin vitro. In vivo studies with PPAR $gamma$ ligands showed enhancementof tumor growth, raising the possibility that reduced immune functionand tumor surveillance may outweigh the direct inhibitory effectsof PPAR $gamma$ ligands on cellular proliferation. Recent findings thatPPAR $gamma$ ligands convey PPAR $gamma$ -independent activities through I $kappa$ Bkinase (IKK) raises important questions about the specific mechanismsthrough which PPAR $gamma$ ligands inhibit cellular proliferation. Weinvestigated the mechanisms regulating the antiproliferative effectof PPAR $gamma$ . Herein PPAR $gamma$ , liganded by either natural (15d-PGJ₂ andPGD₂) or synthetic ligands (BRL49653 and troglitazone), selectivelyinhibited expression of the cyclin D1 gene. The inhibition ofS-phase entry and activity of the cyclin D1-dependent serine-threoninekinase (Cdk) by 15d-PGJ₂ was not observed in PPAR $gamma$ -deficient cells.Cyclin D1 overexpression reversed the S-phase inhibition by 15d-PGJ₂.Cyclin D1 repression was independent of IKK, as prostaglandins(PGs) which bound PPAR $gamma$ but lacked the IKK interactive cyclopentonering carbonyl group repressed cyclin D1. Cyclin D1 repressionby PPAR $gamma$ involved competition for limiting abundance of p300,directed through a c-Fos binding site of the cyclin D1 promoter.15d-PGJ₂ enhanced recruitment of p300 to PPAR $gamma$ but reduced bindingto c-Fos. The identification of distinct pathways through whicheicosanoids regulate anti-inflammatory and antiproliferative effectsmay improve the utility of COX2inhibitors.

^* Corresponding author. Mailing address: The Albert Einstein Cancer Center, Department of Developmental and Molecular Biology,Albert Einstein College of Medicine, Chanin 302, 1300 Morris ParkAve., Bronx, NY 10461. Phone: (718) 430-8662. Fax: (718) 430-8674.E-mail: pestell{at}aecom.yu.edu.

This article has been cited by other articles:

Wei, S., Yang, H.-C., Chuang, H.-C., Yang, J., Kulp, S. K., Lu, P.-J., Lai, M.-D., Chen, C.-S. (2008). A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells. J. Biol. Chem. 283: 26759-26770 [Abstract] [Full Text]
Costa, V, Foti, D, Paonessa, F, Chiefari, E, Palaia, L, Brunetti, G, Gulletta, E, Fusco, A, Brunetti, A (2008). The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) and thiazolidinedione-PPAR{gamma} agonists. Endocr Relat Cancer 15: 325-335 [Abstract] [Full Text]
Kim, H.-J., Kim, J.-Y., Meng, Z., Wang, L. H., Liu, F., Conrads, T. P., Burke, T. R., Veenstra, T. D., Farrar, W. L. (2007). 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-{alpha} via Covalent Modification of DNA-Binding Domain. Cancer Res. 67: 2595-2602 [Abstract] [Full Text]
Annicotte, J.-S., Iankova, I., Miard, S., Fritz, V., Sarruf, D., Abella, A., Berthe, M.-L., Noel, D., Pillon, A., Iborra, F., Dubus, P., Maudelonde, T., Culine, S., Fajas, L. (2006). Peroxisome Proliferator-Activated Receptor {gamma} Regulates E-Cadherin Expression and Inhibits Growth and Invasion of Prostate Cancer.. Mol. Cell. Biol. 26: 7561-7574 [Abstract] [Full Text]
Muranaka, K., Yanagi, Y., Tamaki, Y., Usui, T., Kubota, N., Iriyama, A., Terauchi, Y., Kadowaki, T., Araie, M. (2006). Effects of Peroxisome Proliferator-Activated Receptor {gamma} and Its Ligand on Blood-Retinal Barrier in a Streptozotocin-Induced Diabetic Model.. IOVS 47: 4547-4552 [Abstract] [Full Text]
Aiello, A., Pandini, G., Frasca, F., Conte, E., Murabito, A., Sacco, A., Genua, M., Vigneri, R., Belfiore, A. (2006). Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells. Endocrinology 147: 4463-4475 [Abstract] [Full Text]
Tosca, L., Solnais, P., Ferre, P., Foufelle, F., Dupont, J. (2006). Metformin-Induced Stimulation of Adenosine 5' Monophosphate-Activated Protein Kinase (PRKA) Impairs Progesterone Secretion in Rat Granulosa Cells. Biol. Reprod. 75: 342-351 [Abstract] [Full Text]
Wang, C., Li, Z., Lu, Y., Du, R., Katiyar, S., Yang, J., Fu, M., Leader, J. E., Quong, A., Novikoff, P. M., Pestell, R. G. (2006). Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc. Natl. Acad. Sci. USA 103: 11567-11572 [Abstract] [Full Text]
Weng, J-R, Chen, C-Y, Pinzone, J J, Ringel, M D, Chen, C-S (2006). Beyond peroxisome proliferator-activated receptor {gamma} signaling: the multi-facets of the antitumor effect of thiazolidinediones.. Endocr Relat Cancer 13: 401-413 [Abstract] [Full Text]
He, G., Sung, Y. M., DiGiovanni, J., Fischer, S. M. (2006). Thiazolidinediones Inhibit Insulin-Like Growth Factor-I-Induced Activation of p70S6 Kinase and Suppress Insulin-Like Growth Factor-I Tumor-Promoting Activity. Cancer Res. 66: 1873-1878 [Abstract] [Full Text]
Konopleva, M., Zhang, W., Shi, Y.-X., McQueen, T., Tsao, T., Abdelrahim, M., Munsell, M. F., Johansen, M., Yu, D., Madden, T., Safe, S. H., Hung, M.-C., Andreeff, M. (2006). Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.. Molecular Cancer Therapeutics 5: 317-328 [Abstract] [Full Text]
Sarruf, D. A., Iankova, I., Abella, A., Assou, S., Miard, S., Fajas, L. (2005). Cyclin D3 Promotes Adipogenesis through Activation of Peroxisome Proliferator-Activated Receptor {gamma}. Mol. Cell. Biol. 25: 9985-9995 [Abstract] [Full Text]
Armoni, M., Harel, C., Bar-Yoseph, F., Milo, S., Karnieli, E. (2005). Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements. J. Biol. Chem. 280: 34786-34795 [Abstract] [Full Text]
Banerjee, A. G., Bhattacharyya, I., Vishwanatha, J. K. (2005). Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Molecular Cancer Therapeutics 4: 865-875 [Abstract] [Full Text]
Yin, Y., Russell, R. G., Dettin, L. E., Bai, R., Wei, Z.-L., Kozikowski, A. P., Kopleovich, L., Glazer, R. I. (2005). Peroxisome Proliferator-Activated Receptor {delta} and {gamma} Agonists Differentially Alter Tumor Differentiation and Progression during Mammary Carcinogenesis. Cancer Res. 65: 3950-3957 [Abstract] [Full Text]
Huang, J.-W., Shiau, C.-W., Yang, Y.-T., Kulp, S. K., Chen, K.-F., Brueggemeier, R. W., Shapiro, C. L., Chen, C.-S. (2005). Peroxisome Proliferator-Activated Receptor {gamma}-Independent Ablation of Cyclin D1 by Thiazolidinediones and Their Derivatives in Breast Cancer Cells. Mol. Pharmacol. 67: 1342-1348 [Abstract] [Full Text]
Chen, A., Xu, J. (2005). Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G447-G456 [Abstract] [Full Text]
Nie, M., Corbett, L., Knox, A. J., Pang, L. (2005). Differential Regulation of Chemokine Expression by Peroxisome Proliferator-activated Receptor {gamma} Agonists: INTERACTIONS WITH GLUCOCORTICOIDS AND {beta}2-AGONISTS. J. Biol. Chem. 280: 2550-2561 [Abstract] [Full Text]
Blaschke, F., Leppanen, O., Takata, Y., Caglayan, E., Liu, J., Fishbein, M. C., Kappert, K., Nakayama, K. I., Collins, A. R., Fleck, E., Hsueh, W. A., Law, R. E., Bruemmer, D. (2004). Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries. Circ. Res. 95: e110-e123 [Abstract] [Full Text]
Hilakivi-Clarke, L, Wang, C, Kalil, M, Riggins, R, Pestell, R G (2004). Nutritional modulation of the cell cycle and breast cancer. Endocr Relat Cancer 11: 603-622 [Abstract] [Full Text]
Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D., De Strooper, B. (2004). Peroxisome Proliferator-Activated Receptor {gamma} Induces a Clearance Mechanism for the Amyloid-{beta} Peptide. J. Neurosci. 24: 10908-10917 [Abstract] [Full Text]
Turturro, F., Friday, E., Fowler, R., Surie, D., Welbourne, T. (2004). Troglitazone Acts on Cellular pH and DNA Synthesis through a Peroxisome Proliferator-Activated Receptor {gamma}-Independent Mechanism in Breast Cancer-Derived Cell Lines. Clin. Cancer Res. 10: 7022-7030 [Abstract] [Full Text]
Hulit, J., Wang, C., Li, Z., Albanese, C., Rao, M., Di Vizio, D., Shah, S., Byers, S. W., Mahmood, R., Augenlicht, L. H., Russell, R., Pestell, R. G. (2004). Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice. Mol. Cell. Biol. 24: 7598-7611 [Abstract] [Full Text]
Si, Q., Zhao, M.-L., Morgan, A. C. A., Brosnan, C. F., Lee, S. C. (2004). 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits IFN-Inducible Protein 10/CXC Chemokine Ligand 10 Expression in Human Microglia: Mechanisms and Implications. J. Immunol. 173: 3504-3513 [Abstract] [Full Text]
Nicol, C. J., Yoon, M., Ward, J. M., Yamashita, M., Fukamachi, K., Peters, J. M., Gonzalez, F. J. (2004). PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis. Carcinogenesis 25: 1747-1755 [Abstract] [Full Text]
Sharma, C., Pradeep, A., Pestell, R. G., Rana, B. (2004). Peroxisome Proliferator-activated Receptor {gamma} Activation Modulates Cyclin D1 Transcription via {beta}-Catenin-independent and cAMP-response Element-binding Protein-dependent Pathways in Mouse Hepatocytes. J. Biol. Chem. 279: 16927-16938 [Abstract] [Full Text]
Leung, W K, Bai, A H C, Chan, V Y W, Yu, J, Chan, M W Y, To, K-F, Wu, J-R, Chan, K-K, Fu, Y-G, Chan, F K L, Sung, J J Y (2004). Effect of peroxisome proliferator activated receptor {gamma} ligands on growth and gene expression profiles of gastric cancer cells. Gut 53: 331-338 [Abstract] [Full Text]
Qin, C., Morrow, D., Stewart, J., Spencer, K., Porter, W., Smith, R. III, Phillips, T., Abdelrahim, M., Samudio, I., Safe, S. (2004). A new class of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes. Molecular Cancer Therapeutics 3: 247-260 [Abstract] [Full Text]
Perez-Sala, D., Cernuda-Morollon, E., Canada, F. J. (2003). Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-{Delta}12,14-prostaglandin J2. J. Biol. Chem. 278: 51251-51260 [Abstract] [Full Text]
Lapillonne, H., Konopleva, M., Tsao, T., Gold, D., McQueen, T., Sutherland, R. L., Madden, T., Andreeff, M. (2003). Activation of Peroxisome Proliferator-activated Receptor {gamma} by a Novel Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Growth Arrest and Apoptosis in Breast Cancer Cells. Cancer Res. 63: 5926-5939 [Abstract] [Full Text]
Wang, C., Pattabiraman, N., Zhou, J. N., Fu, M., Sakamaki, T., Albanese, C., Li, Z., Wu, K., Hulit, J., Neumeister, P., Novikoff, P. M., Brownlee, M., Scherer, P. E., Jones, J. G., Whitney, K. D., Donehower, L. A., Harris, E. L., Rohan, T., Johns, D. C., Pestell, R. G. (2003). Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor {gamma} Expression and Transactivation. Mol. Cell. Biol. 23: 6159-6173 [Abstract] [Full Text]
Armoni, M., Kritz, N., Harel, C., Bar-Yoseph, F., Chen, H., Quon, M. J., Karnieli, E. (2003). Peroxisome Proliferator-activated Receptor-{gamma} Represses GLUT4 Promoter Activity in Primary Adipocytes, and Rosiglitazone Alleviates This Effect. J. Biol. Chem. 278: 30614-30623 [Abstract] [Full Text]
Bhatia, B., Maldonado, C. J., Tang, S., Chandra, D., Klein, R. D., Chopra, D., Shappell, S. B., Yang, P., Newman, R. A., Tang, D. G. (2003). Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice Variants. J. Biol. Chem. 278: 25091-25100 [Abstract] [Full Text]
Xu, J., Fu, Y., Chen, A. (2003). Activation of peroxisome proliferator-activated receptor-{gamma} contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G20-G30 [Abstract] [Full Text]
Laurora, S., Pizzimenti, S., Briatore, F., Fraioli, A., Maggio, M., Reffo, P., Ferretti, C., Dianzani, M. U., Barrera, G. (2003). Peroxisome Proliferator-Activated Receptor Ligands Affect Growth-Related Gene Expression in Human Leukemic Cells. J. Pharmacol. Exp. Ther. 305: 932-942 [Abstract] [Full Text]
Bruemmer, D., Yin, F., Liu, J., Berger, J. P., Kiyono, T., Chen, J., Fleck, E., Van Herle, A. J., Forman, B. M., Law, R. E. (2003). Peroxisome Proliferator-Activated Receptor {gamma} Inhibits Expression of Minichromosome Maintenance Proteins in Vascular Smooth Muscle Cells. Mol. Endocrinol. 17: 1005-1018 [Abstract] [Full Text]
Hawcroft, G., Gardner, S. H., Hull, M. A. (2003). Activation of Peroxisome Proliferator-Activated Receptor gamma Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells. J. Pharmacol. Exp. Ther. 305: 632-637 [Abstract] [Full Text]
Qin, C., Burghardt, R., Smith, R., Wormke, M., Stewart, J., Safe, S. (2003). Peroxisome Proliferator-activated Receptor {gamma} Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor {alpha} in MCF-7 Breast Cancer Cells. Cancer Res. 63: 958-964 [Abstract] [Full Text]
Campo, P. A., Das, S., Hsiang, C.-H., Bui, T., Samuel, C. E., Straus, D. S. (2002). Translational Regulation of Cyclin D1 by 15-Deoxy-{Delta}12,14-Prostaglandin J2. Cell Growth Differ. 13: 409-420 [Abstract] [Full Text]
Kopelovich, L., Fay, J. R., Glazer, R. I., Crowell, J. A. (2002). Peroxisome Proliferator-activated Receptor Modulators As Potential Chemopreventive Agents. Molecular Cancer Therapeutics 1: 357-363 [Abstract] [Full Text]
Hawcroft, G., D'Amico, M., Albanese, C., Markham, A. F., Pestell, R. G., Hull, M. A. (2002). Indomethacin induces differential expression of {beta}-catenin, {gamma}-catenin and T-cell factor target genes in human colorectal cancer cells. Carcinogenesis 23: 107-114 [Abstract] [Full Text]
Simonin, M.-A., Bordji, K., Boyault, S., Bianchi, A., Gouze, E., Becuwe, P., Dauca, M., Netter, P., Terlain, B. (2002). PPAR-gamma ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am. J. Physiol. Cell Physiol. 282: C125-C133 [Abstract] [Full Text]
Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., Palmer, C. N. A. (2001). The Peroxisome Proliferator-activated Receptor delta Promotes Lipid Accumulation in Human Macrophages. J. Biol. Chem. 276: 44258-44265 [Abstract] [Full Text]

J. Bacteriol.	J. Virol.	Eukaryot. Cell

Microbiol. Mol. Biol. Rev.	Clin. Vaccine Immunol.	All ASM Journals

Inhibition of Cellular Proliferation through IB Kinase-Independent and Peroxisome Proliferator-Activated Receptor -Dependent Repression of Cyclin D1

Inhibition of Cellular Proliferation through I $kappa$ B Kinase-Independent and Peroxisome Proliferator-Activated Receptor $gamma$ -Dependent Repression of Cyclin D1